产品封面图

A2058

收藏
  • 询价
  • 2026年05月27日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 生长状态

      贴壁生长

    • 年限

      43 years adult

    • 运输方式

      冻存运输

    • 细胞形态

      上皮样

    • 器官来源

      皮肤

    • 库存

      大量

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 相关疾病

      黑色素瘤

    • ATCC Number

      CRL-11147™

    Designations: A2058
    Depositors:  W Stetler-Stevenson
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: skin
    Disease: melanoma
    Derived from metastatic site: lymph node
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications: transfection host
    Receptors: nerve growth factor (NGF), expressed
    laminin, expressed
    Tumorigenic: Yes
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 10,11
    D13S317: 13,14
    D16S539: 9,13
    D5S818: 9,12
    D7S820: 11
    THO1: 7,9
    TPOX: 8
    vWA: 14,18
    Age: 43 years adult
    Gender: male
    Ethnicity: Caucasian
    Comments: This cell line is highly invasive and provides a source of cellular invasion associated proteins (such as the 72000 dalton type IV collagenase.
    Tissue inhibitor of metalloproteinase-2 [TIMP-2], autocrine motility factor and the 67000 dalton laminin receptor.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:6 to 1:12 is recommended
    Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
    recommended serum:ATCC 30-2020
    References: 22590: Fabricant RN, et al. Nerve growth factor receptors on human melanoma cells in culture. Proc. Natl. Acad. Sci. USA 74: 565-569, 1977. PubMed: 265522
    23263: Sherwin SA, et al. Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces. Proc. Natl. Acad. Sci. USA 76: 1288-1292, 1979. PubMed: 375235
    23269: Todaro GJ, et al. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA 77: 5258-5262, 1980. PubMed: 6254071
    23404: Stetler-Stevenson WG, et al. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem. 264: 1353-1356, 1989. PubMed: 2536363
    23549: Stetler-Stevenson WG, et al. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264: 17374-17378, 1989. PubMed: 2793861

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • The Activity of rRNA Resistance Methyltransferases Assessed by MALDI Mass Spectrometry

      , and streptogramin B (MLSB ) antibiotics. The target for Erm methyltransferases is at nucleotide A2058 in 23S rRNA, and methylation occurs before the rRNA has been assembled into 50S ribosomal particles. Erm methyltransferases occur in a phylogenetically wide range

    • 单核苷酸多态性(single nucleotide polymorphisms,SNPs)简介

      signal regulated kinase,ERK),p38和c-Jun N端激酶(c-Jun N-terminal kinase,JNK).它们都是以核转录因子家族活性蛋白-1(activated protein-1 AP-1)和ETS转录因子家族为底物的.MMP-1启动子-1607位点的2G SNP提供了一个ETS结合位点,和-1602位点的AP-1结合位点共同作用,促进MMP-1的转录,因此,2G SNP与1G SNP相比,MMP-1的转录活性提高[172,173].黑色素瘤细胞系A2058

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1320
    博辉生物科技(广州)有限公司
    2025年10月28日询价
    ¥1480
    上海酶研生物科技有限公司
    2025年07月25日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月14日询价
    ¥800
    上海沪震实业有限公司
    2025年07月12日询价
    询价
    ATCC细胞库
    2026年05月27日询价
    A2058
    询价